Jiangsu Apon Medical Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
August 20, 2021 at 04:24 am EDT
Share
Jiangsu Apon Medical Technology Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 213.797 million compared to CNY 134.412 million a year ago. Operating income was CNY 43.109 million compared to CNY 41.542 million a year ago. Net income was CNY 37.184 million compared to CNY 32.839 million a year ago. Basic earnings per share from continuing operations was CNY 0.295 compared to CNY 0.2605 a year ago.
Jiangsu Apon Medical Technology Co., Ltd. is a China-based company which is mainly engaged in research, development, production and sales of medical device products for pain management and nasal care. The Company's main products include medical devices such as micro-computer injection pumps, disposable drug injection pumps, wireless analgesia management systems, pulse oximeters and sensors for pain management, and nasal care applications such as nasal care sprayers. Among them, medical devices used in the field of pain management are mainly used for infusion and monitoring of drug treatment in postoperative, childbirth, cancer and other clinical treatments to alleviate pain in patients; medical devices used in nasal care are mainly used to relieve nasal dryness, nasal congestion and nose discomfort such as bleeding in patients. The Company operates primarily in domestic and overseas markets.